FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity

Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept

Up to 50% of adults taking Zepbound no longer had symptoms associated with OSA after one year

As an Amazon Associate I earn from qualifying purchases.